Index by author

November 01, 2001; Volume 68,Issue 11

B

  1. Bargout, Raed

    1. A 44-year-old man with a pruritic skin rash
      Raed Bargout, MD and Amit Malhotra, MD
      Cleveland Clinic Journal of Medicine November 2001, 68 (11) 952-953;

      Questions and answers on the visible signs of diseases.

E

  1. Eras, Tomris

    1. Recognizing and treating diabetic autonomic neuropathy
      Aaron I. Vinik, MD, PhD and Tomris Eras, MD
      Cleveland Clinic Journal of Medicine November 2001, 68 (11) 928-944;

      Strict glycemic control can slow the onset of diabetic autonomic neuropathy and sometimes reverse it. Other treatments address specific symptoms.

J

  1. Jaber, Wael A.

    1. How often are atrial septal defects associated with thromboembolism? When should they be looked for?
      How often are atrial septal defects associated with thromboembolism? When should they be looked for?
      Wael A. Jaber, MD and Allan L. Klein, MD
      Cleveland Clinic Journal of Medicine November 2001, 68 (11) 954-956;

      In the absence of other causative conditions, an atrial septal defect may be presumed to be the underlying cause of a stroke, especially in younger patients.

K

  1. Kalaycio, Matt E.

    1. Chronic myelogenous leukemia: The news you have and haven’t heard
      Matt E. Kalaycio, MD
      Cleveland Clinic Journal of Medicine November 2001, 68 (11) 913-926;

      One major advance in treating CML was widely publicized. Another, although equally important, was not.

  2. Klein, Allan L.

    1. How often are atrial septal defects associated with thromboembolism? When should they be looked for?
      How often are atrial septal defects associated with thromboembolism? When should they be looked for?
      Wael A. Jaber, MD and Allan L. Klein, MD
      Cleveland Clinic Journal of Medicine November 2001, 68 (11) 954-956;

      In the absence of other causative conditions, an atrial septal defect may be presumed to be the underlying cause of a stroke, especially in younger patients.

L

  1. Leonard, Mandy

    1. Role of alendronate and risedronate in preventing and treating osteoporosis
      Margaret L. Peters, PharmD, Mandy Leonard, PharmD and Angelo A. Licata, MD, PhD
      Cleveland Clinic Journal of Medicine November 2001, 68 (11) 945-951;

      A review of the efficacy and use of the two oral bisphosphonates approved for preventing and treating osteoporosis.

  2. Licata, Angelo A.

    1. Role of alendronate and risedronate in preventing and treating osteoporosis
      Margaret L. Peters, PharmD, Mandy Leonard, PharmD and Angelo A. Licata, MD, PhD
      Cleveland Clinic Journal of Medicine November 2001, 68 (11) 945-951;

      A review of the efficacy and use of the two oral bisphosphonates approved for preventing and treating osteoporosis.

  3. Lipani, John

    1. Cox - 2 Inhibitors and Cardiovascular Risk
      John Lipani, MD
      Cleveland Clinic Journal of Medicine November 2001, 68 (11) 961-962;

      Unless a clear cause-and-effect relationship can be proved between COX-2 inhibitors and cardiovascular events, we should go on using these drugs.

M

  1. Malhotra, Amit

    1. A 44-year-old man with a pruritic skin rash
      Raed Bargout, MD and Amit Malhotra, MD
      Cleveland Clinic Journal of Medicine November 2001, 68 (11) 952-953;

      Questions and answers on the visible signs of diseases.

  2. Mandell, Brian F.

    1. Cox - 2 Inhibitors and Cardiovascular Risk
      Brian F. Mandell, MD, PHD
      Cleveland Clinic Journal of Medicine November 2001, 68 (11) 957-959;

      Even if we do not know with certainty whether COX-2 inhibitors increase the risk of cardiovascular events, we need to incorporate this concern into our practice.

    2. COX-2 inhibitors: Balancing the hope, the hype, and the concern
      Brian F. Mandell, MD, PhD
      Cleveland Clinic Journal of Medicine November 2001, 68 (11) 899;

      When all is said and done, the choice rests with the individual prescribing physician.

  3. Mukherjee, Debabrata

    1. Cox - 2 Inhibitors and Cardiovascular Risk
      Debabrata Mukherjee, MD, Steven E. Nissen, MD and Eric J. Topol, MD
      Cleveland Clinic Journal of Medicine November 2001, 68 (11) 963-964;

      Our study had limitations, but we believe our hypothesis is plausible, our methods were valid, and our conclusions are sound.

N

  1. Nissen, Steven E.

    1. Cox - 2 Inhibitors and Cardiovascular Risk
      Debabrata Mukherjee, MD, Steven E. Nissen, MD and Eric J. Topol, MD
      Cleveland Clinic Journal of Medicine November 2001, 68 (11) 963-964;

      Our study had limitations, but we believe our hypothesis is plausible, our methods were valid, and our conclusions are sound.

P

  1. Peters, Margaret L.

    1. Role of alendronate and risedronate in preventing and treating osteoporosis
      Margaret L. Peters, PharmD, Mandy Leonard, PharmD and Angelo A. Licata, MD, PhD
      Cleveland Clinic Journal of Medicine November 2001, 68 (11) 945-951;

      A review of the efficacy and use of the two oral bisphosphonates approved for preventing and treating osteoporosis.

S

  1. Solomon, Glen D.

    1. Management of primary headache: Serendipity and science
      Glen D. Solomon, MD
      Cleveland Clinic Journal of Medicine November 2001, 68 (11) 904-912;

      A capsule summary of the current management of migraine, chronic tension headache, and cluster headache.

T

  1. Topol, Eric J.

    1. Cox - 2 Inhibitors and Cardiovascular Risk
      Debabrata Mukherjee, MD, Steven E. Nissen, MD and Eric J. Topol, MD
      Cleveland Clinic Journal of Medicine November 2001, 68 (11) 963-964;

      Our study had limitations, but we believe our hypothesis is plausible, our methods were valid, and our conclusions are sound.

V

  1. Vinik, Aaron I.

    1. Recognizing and treating diabetic autonomic neuropathy
      Aaron I. Vinik, MD, PhD and Tomris Eras, MD
      Cleveland Clinic Journal of Medicine November 2001, 68 (11) 928-944;

      Strict glycemic control can slow the onset of diabetic autonomic neuropathy and sometimes reverse it. Other treatments address specific symptoms.

W

  1. Williams, Marc

    1. A 44-year-old man with a pruritic skin rash
      Raed Bargout, MD and Amit Malhotra, MD
      Cleveland Clinic Journal of Medicine November 2001, 68 (11) 952-953;

      Questions and answers on the visible signs of diseases.

Back to top

In this issue